Cargando…
Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy
Cytokine release syndrome (CRS) remains to be a major adverse effect of chimeric antigen receptor T (CAR-T) cell therapy in B-cell acute lymphoblastic leukemia (B-ALL) and lymphoma. It was urgent to explore novel strategy for managing severe CRS. We conducted a clinical trial to assess the safety an...
Autores principales: | Liu, Yanfen, Chen, Xinfeng, Wang, Dao, Li, Hong, Huang, Jianmin, Zhang, Zhen, Qiao, Yingjin, Zhang, Hongling, Zeng, Ying, Tang, Chao, Yang, Shuangning, Wan, Xiaochun, Chen, Youhai H., Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200371/ https://www.ncbi.nlm.nih.gov/pubmed/30198955 http://dx.doi.org/10.1097/CJI.0000000000000243 |
Ejemplares similares
-
Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy
por: Liu, Haiyan, et al.
Publicado: (2019) -
CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
por: Liu, Maoxuan, et al.
Publicado: (2022) -
Cortisol elimination properties during intermitting hemofiltration in patients with acute renal failure
por: Timokhov, V, et al.
Publicado: (2005) -
Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study
por: Sun, Zhiping, et al.
Publicado: (2014) -
Hantavirus cardiopulmonary syndrome successfully treated with
high-volume hemofiltration
por: Bugedo, Guillermo, et al.
Publicado: (2016)